Feedback / Questions
TPI 287 - CNS Pharma
https://cnspharma.com/ir/press-releases/cns-pharmaceuticals-announces-virtual-investor-kol-connect-segment-discussing-glioblastoma-multiforme-gbm-and-lead-product-candidate-tpi-287-46073669
Jun 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next